Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim L. Folorunsho, Adeniyi Kayode Busari, Chidalu Ibeneme, Amarachukwu Diala, Victory Afolabi & Gibson O. Anugwom·Journal of Advances in Medicine and Medical Research·2024
Background: Bulimia nervosa (BN) is a severe eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. Current treatment strategies, including cognitiv...
Open access
Research Article10.9734/jammr/2024/v36i75514
Background: Clozapine is an antipsychotic medication essential for treating treatment-resistant schizophrenia. Its plasma levels are influenced by cytochrome P450 (CYP450) enzymes, particularly CYP1A2. Vaping and traditional smoking may impact clozapine metabolism. Objective: Thi...
Open access
Research Article10.9734/jammr/2024/v36i75484
Background: Pseudocyesis (or pseudocyesis vera) also known as “phantom pregnancy” was previously described according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a false belief of being pregnant that is associated with objective signs and reported sympt...
Open access
Research Article10.9734/jammr/2024/v36i65454
Chidalu N. Ibeneme, Amarachukwu B. Diala, Victory Afolabi, Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim Folorunsho, Adeniyi Kayode Busari, Chinelo Madekwe & Soji Ojo·Journal of Advances in Medicine and Medical Research·2024
Background: Substance use disorders (SUD) represent a critical public health issue, significantly contributing to global morbidity and mortality. Traditional pharmacotherapies for SUD have limited efficacy, necessitating innovative treatment approaches. Ketamine, an N-methyl-D-as...
Open access
Research Article10.9734/jammr/2024/v36i105596